Media

Keep up to date with all the latest news and updates from Virax Biolabs.

 

Virax COO, Nigel McCracken, Exaplains the Latest PAIS IVD Technolgy in His Latest PharmExec.com Interview.

Read more

In His Latest PharmExec.com Interview, Virax COO Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.

Read more

Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.

Read more

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Read more

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Read more

Virax Biolabs Presentation from the 19th World Immune Regulation Meeting: “Evaluation of T cell dysfunction in Post Acute Infection Syndromes”

Read more

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Read more

Tune in now to listen to Dr. Nigel McCracken talk about “The Power of T Cell Immunology: Early Diagnosis, Immunotherapy, & the Future of Global Health” on the Finding Genius podcast

Read more

Join us for Inside Precision Medicine’s FREE State of Precision Medicine Summit on Wednesday, March 5th, 2025.

Read more

“Preparing for Potential Vaccine Regulatory Changes”: Virax CEO, James Foster, discusses how the industry is preparing for potential regulatory changes to vaccine policy

Read more

Virax Biolabs Believes Technology Aligns with Unites States Department of Health and Human Services’ Transparency Priority on Vaccine Efficacy

Read more

“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead

Read more